| Autor: |
Alya, P., Colin, F., Charton, E., Anota, A., De Guibert, S., Ysebaert, L., Manson, G., Daufresne, P., Lhomme, F., Le Bars, L., Bellec, A., Lamy de la Chapelle, T., Houot, R., Moignet, A. |
| Předmět: |
|
| Zdroj: |
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p786-787, 2p |
| Abstrakt: |
B Introduction: b CD19 CAR T-cells can induce prolonged remission in a significant number of patients with relapse/refractory (R/R) lymphoma. REMISSION AFTER CAR T-CELLS: DO PATIENTS RECOVER A NORMAL LIFE? All adult patients with R/R lymphoma treated with CAR T-cells were eligible. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text